Cargando…

Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study

BACKGROUND: Mucopolysaccharidoses (MPS) are a group of inherited lysosomal storage diseases caused by defective enzyme activity involved in the catalysis of glycosaminoglycans. Published data on adult patients with MPS remains scarce. Therefore, the present qualitative survey study was aimed at unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Guffon, Nathalie, Genevaz, Delphine, Lacombe, Didier, Le Peillet Feuillet, Eliane, Bausson, Pascale, Noel, Esther, Maillot, François, Belmatoug, Nadia, Jaussaud, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786416/
https://www.ncbi.nlm.nih.gov/pubmed/36564803
http://dx.doi.org/10.1186/s13023-022-02593-2
_version_ 1784858284396642304
author Guffon, Nathalie
Genevaz, Delphine
Lacombe, Didier
Le Peillet Feuillet, Eliane
Bausson, Pascale
Noel, Esther
Maillot, François
Belmatoug, Nadia
Jaussaud, Roland
author_facet Guffon, Nathalie
Genevaz, Delphine
Lacombe, Didier
Le Peillet Feuillet, Eliane
Bausson, Pascale
Noel, Esther
Maillot, François
Belmatoug, Nadia
Jaussaud, Roland
author_sort Guffon, Nathalie
collection PubMed
description BACKGROUND: Mucopolysaccharidoses (MPS) are a group of inherited lysosomal storage diseases caused by defective enzyme activity involved in the catalysis of glycosaminoglycans. Published data on adult patients with MPS remains scarce. Therefore, the present qualitative survey study was aimed at understanding knowledge of the disease, unmet needs, expectations, care, and overall medical management of adult/adolescent patients with MPS I, II and VI and their caregivers in France. RESULTS: A total of 25 patients (MPS I, n(p) = 11; MPS II, n(p) = 9; MPS VI, n(p) = 5) were included and about 36 in-depth interviews (caregivers alone, n(c) = 8; patients-caregiver pair, n(c+p) = 22; patients alone, n(p) = 6) were conducted. Except one (aged 17 years), all patients were adults (median age: 29 years [17–50]) and diagnosed at median age of 4 years [0.4–30], with mainly mothers as caregivers (n(c) = 16/19). Patients were classified into three groups: Group A, Patients not able to answer the survey question because of a severe cognitive impairment (n(p) = 8); Group B, Patients able to answer the survey question with low or no cognitive impairment and high motor disability (n(p) = 10); and Group C, Patients able to answer the survey question with low or no cognitive impairment and low motor disability (n(p) = 7). All groups were assessed for impact of disease on their daily lives based on a scale of 0–10. Caregivers in Group A were found to be most negatively affected by the disease, except for professional activity, which was most significantly impacted in Group B (4.7 vs. 5.4). The use of orthopaedic/medical equipments, was more prevalent in Groups A and B, versus Group C. Pain management was one of the global unmet need expressed by all groups. Group A caregivers expected better support from childcare facilities, disability clinics, and smooth transition from paediatric care to adult medicine. Similarly, Group B caregivers expected better specialised schools, whereas Group C caregivers expected better psychological support and greater flexibility in weekly infusion schedules for their patients. CONCLUSIONS: The survey concluded that more attention must be paid to the psychosocial status of patients and caregivers. The preference for reference centre for follow-up and treatment, hospitalizations and surgeries were evident. The most significant needs expressed by the patients and caregivers include better understanding of the disease, pain management, monitoring of complications, flexibility in enzyme replacement therapy, home infusions especially for attenuated patients, and improved transitional support from paediatric to adult medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02593-2.
format Online
Article
Text
id pubmed-9786416
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97864162022-12-25 Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study Guffon, Nathalie Genevaz, Delphine Lacombe, Didier Le Peillet Feuillet, Eliane Bausson, Pascale Noel, Esther Maillot, François Belmatoug, Nadia Jaussaud, Roland Orphanet J Rare Dis Research BACKGROUND: Mucopolysaccharidoses (MPS) are a group of inherited lysosomal storage diseases caused by defective enzyme activity involved in the catalysis of glycosaminoglycans. Published data on adult patients with MPS remains scarce. Therefore, the present qualitative survey study was aimed at understanding knowledge of the disease, unmet needs, expectations, care, and overall medical management of adult/adolescent patients with MPS I, II and VI and their caregivers in France. RESULTS: A total of 25 patients (MPS I, n(p) = 11; MPS II, n(p) = 9; MPS VI, n(p) = 5) were included and about 36 in-depth interviews (caregivers alone, n(c) = 8; patients-caregiver pair, n(c+p) = 22; patients alone, n(p) = 6) were conducted. Except one (aged 17 years), all patients were adults (median age: 29 years [17–50]) and diagnosed at median age of 4 years [0.4–30], with mainly mothers as caregivers (n(c) = 16/19). Patients were classified into three groups: Group A, Patients not able to answer the survey question because of a severe cognitive impairment (n(p) = 8); Group B, Patients able to answer the survey question with low or no cognitive impairment and high motor disability (n(p) = 10); and Group C, Patients able to answer the survey question with low or no cognitive impairment and low motor disability (n(p) = 7). All groups were assessed for impact of disease on their daily lives based on a scale of 0–10. Caregivers in Group A were found to be most negatively affected by the disease, except for professional activity, which was most significantly impacted in Group B (4.7 vs. 5.4). The use of orthopaedic/medical equipments, was more prevalent in Groups A and B, versus Group C. Pain management was one of the global unmet need expressed by all groups. Group A caregivers expected better support from childcare facilities, disability clinics, and smooth transition from paediatric care to adult medicine. Similarly, Group B caregivers expected better specialised schools, whereas Group C caregivers expected better psychological support and greater flexibility in weekly infusion schedules for their patients. CONCLUSIONS: The survey concluded that more attention must be paid to the psychosocial status of patients and caregivers. The preference for reference centre for follow-up and treatment, hospitalizations and surgeries were evident. The most significant needs expressed by the patients and caregivers include better understanding of the disease, pain management, monitoring of complications, flexibility in enzyme replacement therapy, home infusions especially for attenuated patients, and improved transitional support from paediatric to adult medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02593-2. BioMed Central 2022-12-23 /pmc/articles/PMC9786416/ /pubmed/36564803 http://dx.doi.org/10.1186/s13023-022-02593-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Guffon, Nathalie
Genevaz, Delphine
Lacombe, Didier
Le Peillet Feuillet, Eliane
Bausson, Pascale
Noel, Esther
Maillot, François
Belmatoug, Nadia
Jaussaud, Roland
Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study
title Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study
title_full Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study
title_fullStr Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study
title_full_unstemmed Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study
title_short Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study
title_sort understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses i, ii and vi patients and their caregivers in france: a survey study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786416/
https://www.ncbi.nlm.nih.gov/pubmed/36564803
http://dx.doi.org/10.1186/s13023-022-02593-2
work_keys_str_mv AT guffonnathalie understandingthechallengesunmetneedsandexpectationsofmucopolysaccharidosesiiiandvipatientsandtheircaregiversinfranceasurveystudy
AT genevazdelphine understandingthechallengesunmetneedsandexpectationsofmucopolysaccharidosesiiiandvipatientsandtheircaregiversinfranceasurveystudy
AT lacombedidier understandingthechallengesunmetneedsandexpectationsofmucopolysaccharidosesiiiandvipatientsandtheircaregiversinfranceasurveystudy
AT lepeilletfeuilleteliane understandingthechallengesunmetneedsandexpectationsofmucopolysaccharidosesiiiandvipatientsandtheircaregiversinfranceasurveystudy
AT baussonpascale understandingthechallengesunmetneedsandexpectationsofmucopolysaccharidosesiiiandvipatientsandtheircaregiversinfranceasurveystudy
AT noelesther understandingthechallengesunmetneedsandexpectationsofmucopolysaccharidosesiiiandvipatientsandtheircaregiversinfranceasurveystudy
AT maillotfrancois understandingthechallengesunmetneedsandexpectationsofmucopolysaccharidosesiiiandvipatientsandtheircaregiversinfranceasurveystudy
AT belmatougnadia understandingthechallengesunmetneedsandexpectationsofmucopolysaccharidosesiiiandvipatientsandtheircaregiversinfranceasurveystudy
AT jaussaudroland understandingthechallengesunmetneedsandexpectationsofmucopolysaccharidosesiiiandvipatientsandtheircaregiversinfranceasurveystudy